SSPs for HRT

For five HRT medicines affected by ongoing supply disruptions, a total of 13 individual SSPs have been issued by DHSC which allow either:

  • Restriction of the quantity supplied – where a prescription has a duration of more than three months and supplies are available, an equivalent of three months’ supply will be permitted in accordance with the SSP for the prescribed medicine; or
  • Substitution with a specific alternative product – where the prescribed duration of treatment is three months or less and supplies are unavailable, a pharmacist can supply a specific alternative product sufficient to provide a reasonable estimate of the prescribed duration of treatment, if deemed clinically appropriate; or
  • Substitution with a specific alternative product AND restriction of the quantity supplied – where a prescription has a duration of more than three months and supplies are unavailable, the SSPs will allow pharmacists to provide three months’ supply of specific alternative product.

Further details and supporting information is available on the PSNC website.


Endorsement guidance and FAQs for HRT SSPs now live

PSNC and the NHSBSA have now published endorsement guidance and FAQs for the new HRT SSPs announced on Friday 20th May.

Due to the number of different HRT SSPs that are now live, pharmacists must ensure they follow the correct endorsement requirements as per the supporting guidance published on the NHSBSA website. Incorrect endorsements will affect pharmacy payments.

Read the NHSBSA endorsement guidance and PSNC’s HRT SSPs FAQs